64 research outputs found
Recommended from our members
VAR2CSA Signatures of High Plasmodium falciparum Parasitemia in the Placenta
Plasmodium falciparum infected erythrocytes (IE) accumulate in the placenta through the interaction between Duffy-binding like (DBL) domains of parasite-encoded ligand VAR2CSA and chondroitin sulphate-A (CSA) receptor. Polymorphisms in these domains, including DBL2X and DBL3X, may affect their antigenicity or CSA-binding affinity, eventually increasing parasitemia and its adverse effects on pregnancy outcomes. A total of 373 DBL2X and 328 DBL3X sequences were obtained from transcripts of 20 placental isolates infecting Mozambican women, resulting in 176 DBL2X and 191 DBL3X unique sequences at the protein level. Sequence alignments were divided in segments containing combinations of correlated polymorphisms and the association of segment sequences with placental parasite density was tested using Bonferroni corrected regression models, taking into consideration the weight of each sequence in the infection. Three DBL2X and three DBL3X segments contained signatures of high parasite density (P<0.003) that were highly prevalent in the parasite population (49–91%). Identified regions included a flexible loop that contributes to DBL3X-CSA interaction and two DBL3X motifs with evidence of positive natural selection. Limited antibody responses against signatures of high parasite density among malaria-exposed pregnant women could not explain the increased placental parasitemia. These results suggest that a higher binding efficiency to CSA rather than reduced antigenicity might provide a biological advantage to parasites with high parasite density signatures in VAR2CSA. Sequences contributing to high parasitemia may be critical for the functional characterization of VAR2CSA and the development of tools against placental malaria
VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
Plasmodium falciparum infected erythrocytes (IE) accumulate in the placenta through the interaction between Duffy-binding like (DBL) domains of parasite-encoded ligand VAR2CSA and chondroitin sulphate-A (CSA) receptor. Polymorphisms in these domains, including DBL2X and DBL3X, may affect their antigenicity or CSA-binding affinity, eventually increasing parasitemia and its adverse effects on pregnancy outcomes. A total of 373 DBL2X and 328 DBL3X sequences were obtained from transcripts of 20 placental isolates infecting Mozambican women, resulting in 176 DBL2X and 191 DBL3X unique sequences at the protein level. Sequence alignments were divided in segments containing combinations of correlated polymorphisms and the association of segment sequences with placental parasite density was tested using Bonferroni corrected regression models, taking into consideration the weight of each sequence in the infection. Three DBL2X and three DBL3X segments contained signatures of high parasite density (P<0.003) that were highly prevalent in the parasite population (49-91%). Identified regions included a flexible loop that contributes to DBL3X-CSA interaction and two DBL3X motifs with evidence of positive natural selection. Limited antibody responses against signatures of high parasite density among malaria-exposed pregnant women could not explain the increased placental parasitemia. These results suggest that a higher binding efficiency to CSA rather than reduced antigenicity might provide a biological advantage to parasites with high parasite density signatures in VAR2CSA. Sequences contributing to high parasitemia may be critical for the functional characterization of VAR2CSA and the development of tools against placental malaria
Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life
Background: Factors driving inter-individual differences in immune responses upon different types of prenatal malaria
exposure (PME) and subsequent risk of malaria in infancy remain poorly understood. In this study, we examined the
impact of four types of PME (i.e., maternal peripheral infection and placental acute, chronic, and past infections) on
both spontaneous and toll-like receptors (TLRs)-mediated cytokine production in cord blood and how these innate
immune responses modulate the risk of malaria during the first year of life.
Methods: We conducted a birth cohort study of 313 mother-child pairs nested within the COSMIC clinical trial
(NCT01941264), which was assessing malaria preventive interventions during pregnancy in Burkina Faso. Malaria
infections during pregnancy and infants’ clinical malaria episodes detected during the first year of life were recorded.
Supernatant concentrations of 30 cytokines, chemokines, and growth factors induced by stimulation of cord blood
with agonists of TLRs 3, 7/8, and 9 were measured by quantitative suspension array technology. Crude concentrations
and ratios of TLR-mediated cytokine responses relative to background control were analyzed.
Results: Spontaneous production of innate immune biomarkers was significantly reduced in cord blood of infants
exposed to malaria, with variation among PME groups, as compared to those from the non-exposed control group.
However, following TLR7/8 stimulation, which showed higher induction of cytokines/chemokines/growth factors than
TLRs 3 and 9, cord blood cells of infants with evidence of past placental malaria were hyper-responsive in comparison
to those of infants not-exposed. In addition, certain biomarkers, which levels were significantly modified depending on
the PME category, were independent predictors of either malaria risk (GM-CSF TLR7/8 crude) or protection (IL-12 TLR7/
8 ratio and IP-10 TLR3 crude, IL-1RA TLR7/8 ratio) during the first year of life.
Conclusions: These findings indicate that past placental malaria has a profound effect on fetal immune system and
that the differential alterations of innate immune responses by PME categories might drive heterogeneity between
individuals to clinical malaria susceptibility during the first year of lif
Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life.
Background: Although consensus exists that malaria in pregnancy (MiP) increases the risk of malaria in infancy, and eventually nonmalarial fevers (NMFs), there is a lack of conclusive evidence of benefits of MiP preventive strategies in infants. Methods: In Burkina Faso, a birth cohort study was nested to a clinical trial assessing the effectiveness of a community-based scheduled screening and treatment of malaria in combination with intermittent preventive treatment with sulfadoxine-pyrimethamine (CSST/IPTp-SP) to prevent placental malaria. Clinical episodes and asymptomatic infections were monitored over 1 year of follow-up to compare the effect of CSST/IPTp-SP and standard IPTp-SP on malaria and NMFs. Results: Infants born during low-transmission season from mothers receiving CSST/IPTp-SP had a 26% decreased risk of experiencing a first clinical episode (hazard ratio, 0.74 [95% confidence interval, .55-0.99]; P = .047). CSST/IPTp-SP interacted with birth season and gravidity to reduce the incidence of NMFs. No significant effects of CSST/IPTp-SP on the incidence of clinical episodes, parasite density, and Plasmodium falciparum infections were observed. Conclusions: Our findings indicate that CSST/IPTp-SP strategy may provide additional protection against both malaria and NMFs in infants during the first year of life, and suggest that malaria control interventions during pregnancy could have long-term benefits in infants
High Proportion of Genome-Wide Homology and Increased Pretreatment pvcrt Levels in Plasmodium vivax Late Recurrences: a Chloroquine Therapeutic Efficacy Study.
Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most countries where malaria is endemic. Monitoring P. vivax CQ resistance (CQR) is critical but remains challenged by the difficulty to distinguish real treatment failure from reinfection or liver relapse. The therapeutic efficacy of CQ against uncomplicated P. vivax malaria was evaluated in Gia Lai Province, Vietnam. Sixty-seven patients were enrolled and followed for 42 days using microscopy and quantitative PCR. Adequate clinical and parasitological response (ACPR) was 100% (66/66) on day 28 but 75.4% (49/65) on day 42. Eighteen recurrences (27.7%) were detected, with a median time to recurrence of 42 days (interquartile range [IQR], 35 to 42) and blood CQ concentration of 98% identity by descent to paired day 0 samples. This study shows that CQ remained largely efficacious to treat P. vivax in Gia Lai; i.e., recurrences occurred late (>day 28) and in the presence of low blood CQ concentrations. However, the combination of both WGS and gene expression analysis (pvcrt) data with clinical data (PCT) allowed us to identify potential emergence of low-grade CQR, which should be closely monitored. (This study has been registered at ClinicalTrials.gov under identifier NCT02610686.)
Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life.
BACKGROUND: Factors driving inter-individual differences in immune responses upon different types of prenatal malaria exposure (PME) and subsequent risk of malaria in infancy remain poorly understood. In this study, we examined the impact of four types of PME (i.e., maternal peripheral infection and placental acute, chronic, and past infections) on both spontaneous and toll-like receptors (TLRs)-mediated cytokine production in cord blood and how these innate immune responses modulate the risk of malaria during the first year of life. METHODS: We conducted a birth cohort study of 313 mother-child pairs nested within the COSMIC clinical trial (NCT01941264), which was assessing malaria preventive interventions during pregnancy in Burkina Faso. Malaria infections during pregnancy and infants' clinical malaria episodes detected during the first year of life were recorded. Supernatant concentrations of 30 cytokines, chemokines, and growth factors induced by stimulation of cord blood with agonists of TLRs 3, 7/8, and 9 were measured by quantitative suspension array technology. Crude concentrations and ratios of TLR-mediated cytokine responses relative to background control were analyzed. RESULTS: Spontaneous production of innate immune biomarkers was significantly reduced in cord blood of infants exposed to malaria, with variation among PME groups, as compared to those from the non-exposed control group. However, following TLR7/8 stimulation, which showed higher induction of cytokines/chemokines/growth factors than TLRs 3 and 9, cord blood cells of infants with evidence of past placental malaria were hyper-responsive in comparison to those of infants not-exposed. In addition, certain biomarkers, which levels were significantly modified depending on the PME category, were independent predictors of either malaria risk (GM-CSF TLR7/8 crude) or protection (IL-12 TLR7/8 ratio and IP-10 TLR3 crude, IL-1RA TLR7/8 ratio) during the first year of life. CONCLUSIONS: These findings indicate that past placental malaria has a profound effect on fetal immune system and that the differential alterations of innate immune responses by PME categories might drive heterogeneity between individuals to clinical malaria susceptibility during the first year of life
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
We describe the MalariaGEN Pf7 data resource, the seventh release of Plasmodium falciparum genome variation data from the MalariaGEN network. It comprises over 20,000 samples from 82 partner studies in 33 countries, including several malaria endemic regions that were previously underrepresented. For the first time we include dried blood spot samples that were sequenced after selective whole genome amplification, necessitating new methods to genotype copy number variations. We identify a large number of newly emerging crt mutations in parts of Southeast Asia, and show examples of heterogeneities in patterns of drug resistance within Africa and within the Indian subcontinent. We describe the profile of variations in the C-terminal of the csp gene and relate this to the sequence used in the RTS,S and R21 malaria vaccines. Pf7 provides high-quality data on genotype calls for 6 million SNPs and short indels, analysis of large deletions that cause failure of rapid diagnostic tests, and systematic characterisation of six major drug resistance loci, all of which can be freely downloaded from the MalariaGEN website
Malària durant l'embaràs: immunitat materna i expressió de gens implicats en la citoadhesió de "Plasmodium falciparum"
[cat] El risc d’infecció per Plasmodium falciparum, el paràsit causant de la malària, augmenta durant l’embaràs. La disminució del risc d’infecció en embarassos successius s’atribueix a l’adquisició d’anticossos contra eritròcits infectats a la placenta, els quals expressen en la seva superfície la proteïna VAR2CSA. Aquesta proteïna pertany a la família de lligands polimòrfics PfEMP1, i permet l’adhesió dels paràsits a la placenta mitjançant la seva interacció amb el receptor humà sulfat de condroitina A. Per aquest motiu, VAR2CSA és actualment un candidat a vacuna per a la prevenció de la malària en dones embarassades. No obstant, altres mecanismes com la modulació general de la immunitat durant l’embaràs podrien contribuir a augmentar la susceptibilitat a la infecció. A més, la contribució de paràsits que expressin membres de la família PfEMP1 diferents de VAR2CSA no s’ha estudiat en detall en les infeccions maternes. Per tant, és necessària una millor comprensió dels mecanismes moleculars implicats en la fisiopatologia de la malària en dones embarassades, a fi de desenvolupar intervencions específiques i efectives. Els treballs inclosos en aquesta tesi doctoral demostren que: i) una baixa resposta d’anticossos contra VAR2CSA però també una disminució general dels nivells de IgG poden contribuir a augmentar el risc de malària en el primer embaràs; ii) la infecció de la placenta per P. falciparum estimula la producció d’anticossos amb especificitats múltiples, suggerint que els anticossos en el moment del part són un indicador d’exposició més que de protecció; iii) tot i que la població de paràsits que expressen VAR2CSA és majoritària, paràsits que expressen altres PfEMP1 són freqüents en les infeccions maternes; iv) la presència de determinades variants de seqüència en les regions polimòrfiques de VAR2CSA s’associen a un increment de la densitat de paràsits a la placenta. A nivell immunològic, aquests resultats impliquen que els nivells d’anticossos en fases inicials de l’embaràs o bé altres mecanismes com les respostes cel•lulars podrien ser més rellevants en el control de la infecció, comparat amb els nivells d’anticossos al final de l’embaràs. A nivell molecular, vacunes específiques per a prevenir la malària en dones embarassades podrien ser més efectives si incorporessin aquelles variants VAR2CSA potencialment més patogèniques, així com epítops rellevants d’altres PfEMP1 o altres antígens conservats de P. falciparum.[eng] The thesis project entitled Malaria during pregnancy: maternal immunity and expression of Plasmodium falciparum citoadhesion-related genes focuses on var gene expression patterns in maternal P.falciparum isolates as well as host immune responses against PfEMP1 and merozoite antigens in pregnant women from Mozambique
Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.
BACKGROUND:Malaria remains a significant health problem in Mozambique, particularly in the case of pregnant women and children less than five years old. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) is recommended for preventing malaria in pregnancy (MiP). Despite the widespread use and cost-effectiveness of IPTp-SP, coverage remains low. In this study, we explored factors limiting access to and use of IPTp-SP in a rural part of Mozambique. METHODS AND FINDINGS:We performed a qualitative study using semi-structured interviews to collect data from 46 pregnant women and four health workers in Chókwè, a rural area of southern Mozambique. Data were transcribed, translated where appropriate, manually coded, and the content analyzed according to key themes. The women interviewed were not aware of the risks of MiP or the benefits of its prevention. Delays in accessing antenatal care, irregular attendance of visits, and insufficient time for proper antenatal care counselling by health workers were driving factors for inadequate IPTp delivery. CONCLUSIONS:Pregnant women face substantial barriers in terms of optimal IPTp-SP uptake. Health system barriers and poor awareness of the risks and consequences of MiP and of the measures available for its prevention were identified as the main factors influencing access to and use of IPTp-SP. Implementation of MiP prevention strategies must be improved through intensive community health education and increased access to other sources of information. Better communication between health workers and ANC clients and better knowledge of national ANC and IPTp policies are important
Access to and use of preventive intermittent treatment for Malaria during pregnancy : a qualitative study in the Chokwe district, Southern Mozambique
BackgroundMalaria remains a significant health problem in Mozambique, particularly in the case of pregnant women and children less than five years old. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) is recommended for preventing malaria in pregnancy (MiP). Despite the widespread use and cost-effectiveness of IPTp-SP, coverage remains low. In this study, we explored factors limiting access to and use of IPTp-SP in a rural part of Mozambique.Methods and findingsWe performed a qualitative study using semi-structured interviews to collect data from 46 pregnant women and four health workers in Chókwè, a rural area of southern Mozambique. Data were transcribed, translated where appropriate, manually coded, and the content analyzed according to key themes. The women interviewed were not aware of the risks of MiP or the benefits of its prevention. Delays in accessing antenatal care, irregular attendance of visits, and insufficient time for proper antenatal care counselling by health workers were driving factors for inadequate IPTp delivery.ConclusionsPregnant women face substantial barriers in terms of optimal IPTp-SP uptake. Health system barriers and poor awareness of the risks and consequences of MiP and of the measures available for its prevention were identified as the main factors influencing access to and use of IPTp-SP. Implementation of MiP prevention strategies must be improved through intensive community health education and increased access to other sources of information. Better communication between health workers and ANC clients and better knowledge of national ANC and IPTp policies are important.</div
- …